Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

General ticker "SHEZF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $689.2M (TTM average)

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. does not follow the US Stock Market performance with the rate: nan%.

Estimated limits based on current volatility of 0.0%: low 0.47$, high 0.47$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-05-28, amount 0.03$ (Y6.39%)
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.31$, 0.63$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.30$, 0.60$]

Short-term SHEZF quotes

Long-term SHEZF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue CNY5,445.57MM CNY5,280.71MM CNY5,478.98MM
Operating Expenses CNY6,306.48MM CNY4,539.40MM CNY4,843.01MM
Operating Income CNY-860.91MM CNY741.31MM CNY635.97MM
Non-Operating Income CNY-67.42MM CNY-15.08MM CNY-233.73MM
Interest Expense CNY223.22MM CNY141.18MM CNY71.44MM
R&D Expense CNY184.66MM CNY212.04MM CNY226.16MM
Income(Loss) CNY-928.33MM CNY726.23MM CNY402.24MM
Taxes CNY-126.17MM CNY101.31MM CNY59.60MM
Profit(Loss)* CNY-783.26MM CNY646.74MM CNY349.49MM
Stockholders Equity CNY11,913.15MM CNY12,148.67MM CNY12,030.94MM
Inventory CNY6,654.11MM CNY5,393.95MM CNY4,446.65MM
Assets CNY19,203.42MM CNY17,343.52MM CNY16,631.76MM
Operating Cash Flow CNY398.22MM CNY2,194.13MM CNY1,712.95MM
Capital expenditure CNY444.88MM CNY202.77MM CNY121.10MM
Investing Cash Flow CNY1,221.57MM CNY-415.05MM CNY-872.75MM
Financing Cash Flow CNY-1,210.17MM CNY-2,139.73MM CNY-1,094.57MM
Earnings Per Share** CNY-0.53 CNY0.44 CNY0.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.